Why is Link Pharma Chem falling/rising?

As of 09-Sep, Link Pharma Chem Ltd's stock price is currently at 34.27, reflecting a decrease of 0.48, or 1.38%. The stock has underperformed its sector by 1.32% today and has experienced a consecutive decline over the last two days, resulting in a total drop of 3.46%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company has shown weak long-term fundamental strength, with a staggering -183.49% CAGR growth in operating profits over the past five years, and its ability to service debt is concerning, as indicated by a poor EBIT to Interest ratio of 0.79. Furthermore, the company reported flat results for the quarter ending June 25, with net sales and profit after tax both declining by 21.03%.
In the broader market context, the stock's performance over the past week shows a modest gain of 0.79%, while the benchmark Sensex has increased by 1.18%. However, over the longer term, Link Pharma Chem has significantly underperformed, with a year-to-date return of -16.41% compared to the Sensex's gain of 3.79%. This underperformance is compounded by the company's negative operating profits and a return on equity of only 5.21%, indicating low profitability relative to shareholders' funds. Overall, the combination of weak financial fundamentals, declining sales, and poor stock performance relative to the market contributes to the stock's downward movement.